A major advance in cancer study is emerging with the use of mini-antibodies to reactivate damaged p53. This essential malignant inhibitor protein is frequently disabled in many forms of tumors, causing uncontrolled https://ragingbookmarks.com/story21959298/nanobodies-reactivate-tumor-suppressor-p53-a-potential-pathway-for-malignant-treatment